Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity

SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER BEVACIZUMAB OR RANIBIZUMAB TREATMENT FOR RETINOPATHY OF PREMATURITY

(2017) Wei-Chi Wu et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY

(2017) Guoming Zhang et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

The Process of Retinal Vascularization after Anti-VEGF Treatment in Retinopathy of Prematurity: A Comparison Study between Ranibizumab and Bevacizumab

(2016) Emine Alyamaç Sukgen et al.   OPHTHALMOLOGICA

Effects of Intravitreal Ranibizumab in the Treatment of Retinopathy of Prematurity in Chinese Infants

(2015) Zuohuizi Yi et al.   CURRENT EYE RESEARCH

Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age-related macular degeneration: a randomised, prospective trial

(2014) Claus Zehetner et al.   ACTA OPHTHALMOLOGICA

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

(2014) Robert L Avery et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Vascular Endothelial Growth Factor Antagonist Therapy for Retinopathy of Prematurity

(2014) M. Elizabeth Hartnett   CLINICS IN PERINATOLOGY

Structural, Visual and Refractive Outcomes of Intravitreal Aflibercept Injection in High-Risk Prethreshold Type 1 Retinopathy of Prematurity

(2014) Abdelrahman G. Salman et al.   OPHTHALMIC RESEARCH

Screening Examination of Premature Infants for Retinopathy of Prematurity

(2013) et al.   PEDIATRICS

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

(2012) Nicholas Papadopoulos et al.   ANGIOGENESIS

Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity

(2011) Helen A. Mintz-Hittner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Myositis Ossificans

(2011) Deborah A. Martin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

(2008) Magali Saint-Geniez et al.   PLoS One